Overview:

The Hypercholesteremia Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the cholesterol market, as well as sales of leading drugs and therapies, and information on future therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.   

I.              Overview

General description of hypercholesteremia

Risk categories

II.             prevalence

Prevalence Table: High Total Cholesterol (US, Canada, Chile, Mexico, UK, Germany, Japan, China, India, Australia, Northwest Europe, South Europe, East Europe)

Prevalence Table: High LDL Cholesterol (US, China, India)

Prevalence Table: Low LDL Cholesterol (US, Chile, Japan, China, India)

Prevalence Tabel: High Triglycerides (US, Chile)

III.            Therapeutic effects of lowering cholesterol

Low density lipoprotein treatment cutoff table

IV.           treatment

V.            dosing and treatment costs

Dosing for commonly prescribed drugs

Costs for commonly prescribed drugs

VI.           market size

Overall market size

Sales information for key pharmaceuticals

VII.          comments

VIII.         references/resources